Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × HA 22 × Clear all

Status

Approved for marketing 1

Sponsor Class

NETWORK 1 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Hairy Cell 1 Leukemia 1

Interventions

pembrolizumab 868 Carboplatin 812 Paclitaxel 797 Gemcitabine 669 Cisplatin 642 Docetaxel 606 Bevacizumab 542 Nivolumab 431 Pemetrexed 418 Cyclophosphamide 406 Capecitabine 401 Fluorouracil 343 Dexamethasone 339 Rituximab 336 Oxaliplatin 293 Injections 285 atezolizumab 267 Trastuzumab 263 Cetuximab 244 Leucovorin 237 Irinotecan 221 130-nm albumin-bound paclitaxel 221 Prednisone 220 Doxorubicin 212 Ipilimumab 201 Lenalidomide 197 Fulvestrant 190 fludarabine 182 durvalumab 178 Drug Therapy 173

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03501615 2020-06-29

MOXE

AstraZeneca

Approved for marketing

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡